Cancer cells survive with survivin
- 21 August 2008
- journal article
- review article
- Published by Wiley in Cancer Science
- Vol. 99 (9) , 1709-1714
Abstract
Survivin has multiple functions including cytoprotection, inhibition of cell death, and cell‐cycle regulation, especially at the mitotic process stage, all of which favor cancer survival. Many studies on clinical specimens have shown that survivin expression is invariably up‐regulated in human cancers and is associated with resistance to chemotherapy or radiation therapy, and linked to poor prognosis, suggesting that cancer cells survive with survivin. It is also reported that survivin inhibition, alone or in combination with the other therapies, induces or enhances apoptosis and mitotic catastrophe in tumor cells. Moreover, certain antitumor agents can reduce survivin expression. These findings suggest that survivin may be a promising molecular target against human malignancies. (Cancer Sci 2008; 99: 1709–1714)Keywords
This publication has 78 references indexed in Scilit:
- Oxaliplatin induces mitotic catastrophe and apoptosis in esophageal cancer cellsCancer Science, 2007
- Low-Dose Oxaliplatin Enhances the Antitumor Efficacy of Paclitaxel in Human Gastric Cancer Cell LinesDigestion, 2006
- Cross-talk between Epidermal Growth Factor Receptor and Hypoxia-inducible Factor-1α Signal Pathways Increases Resistance to Apoptosis by Up-regulating Survivin Gene ExpressionJournal of Biological Chemistry, 2006
- Persistent Activation of Stat3 Signaling Induces Survivin Gene Expression and Confers Resistance to Apoptosis in Human Breast Cancer CellsClinical Cancer Research, 2006
- Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulationMolecular Cancer Therapeutics, 2005
- Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cellsSurgery, 2005
- A Potent Immunogenic General Cancer Vaccine That Targets Survivin, an Inhibitor of Apoptosis ProteinsClinical Cancer Research, 2005
- Validating survivin as a cancer therapeutic targetNature Reviews Cancer, 2003
- IAP proteins: blocking the road to death's doorNature Reviews Molecular Cell Biology, 2002
- Survivin as a Radioresistance Factor in Pancreatic CancerJapanese Journal of Cancer Research, 2000